FDA Recall Terminated

Stanbio TDM/Beta-Hydroxybutyrate Linearity Standards, packaged in boxes containing Levels 1-6, 1 x 4 mL each, REF 2450-604, Medline catalog number S-O2450604, IVD.

Recall: Z-0933-2022 · Initiated March 8, 2022

Recall

Recall Number
Z-0933-2022
Event Number
89801
Firm
MEDLINE INDUSTRIES, LP Northfield
FEI Number
1417592
Product Code
DKB
Status
Terminated
Root Cause
Storage
Initiated
March 8, 2022
Terminated
February 27, 2023
Address
3 Lakes Dr, Northfield, IL, 60093-2753

Description

Stanbio TDM/Beta-Hydroxybutyrate Linearity Standards, packaged in boxes containing Levels 1-6, 1 x 4 mL each, REF 2450-604, Medline catalog number S-O2450604, IVD.

Reason

The product was stored incorrectly due to improper storage controls which may lead to delayed results.

Action

The recalling firm issued letters dated 3/8/2022 via regular mail on 3/8/2022. The letter explained the product was stored incorrectly due to improper storage controls. The consignee was to immediately check their inventory for the affected lot numbers, quarantine it, and destroy it. The enclosed destruction form was to be completed listing the quantity of affected product destroyed and once the form was returned, they would receive credit. If the product was transferred to another individual or location, they were to notify them of the recall communication. On 3/17/2022, the recalling firm issued an amended recall letter dated 3/17/2022 that notified the consignee there was an error in one of the lot numbers (1747003) listed in the original letter dated 3/8/2022 and the correct lot number is 174703. The other lot numbers were also listed in the amended letter. Again, return of the amended Destruction Form listing all of the lot numbers was requested containing the same instructions as the original Destruction Form.

Distribution

Distribution was made to AL, FL, NE OH, TX, WA, and WI. There was no foreign/military/government distribution.

Quantity

10 boxes